ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,061.82
      -1.20%
      US Tech 100
      17,248.40
      0.03%
      Dow Jones
      37,735.11
      -0.65%
      Brent Oil
      89.28
      -0.66%
      Bitcoin
      62,606.79
      -1.29%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Alpine Immune Sciences Inc (ALPN)

      7. Alpine Immune Sciences Inc (ALPN) News

      ALPN Alpine Immune Sciences Inc

      64.40
      -0.02 (-0.03%)
      Pre Market
      Last Updated: 07:00:00
      Delayed by 15 minutes
      Company Name Stock Ticker Symbol Market Type
      Alpine Immune Sciences Inc ALPN NASDAQ Common Stock
        Price Change Change Percent Stock Price Last Traded
      Upgrade Icon
      -0.02 -0.03% 64.40 07:00:00
      Open Price Low Price High Price Close Price Prev Close
      64.42
      more quote information »

      Recent News

      Date Time Source Heading
      4/11/202416:27PRNUSKuehn Law Encourages ALPN, JBT, ELYM, and HRT Investors to..
      4/11/202407:24IHMARKETNEWSCostco Increases Dividend by 14%, Meta Introduces ‘Artemis’..
      4/10/202416:15BWAlpine Immune Sciences Shares Updated Clinical Data from..
      4/10/202416:01BWVertex Enters Into Agreement to Acquire Alpine Immune..
      4/01/202409:00BWAlpine Immune Sciences to Present Updated Clinical Data for..
      3/21/202407:45BWAlpine Immune Sciences Presents New Translational Data on..
      3/20/202416:30BWAlpine Immune Sciences to Participate in Upcoming H.C...
      3/18/202416:05BWAlpine Immune Sciences Provides Corporate Update and Full..
      3/07/202416:30BWAlpine Immune Sciences to Report Fourth Quarter and Full..
      2/26/202416:30BWAlpine Immune Sciences to Participate in Two Upcoming..
      2/14/202416:43EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
      2/14/202409:22EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
      2/07/202416:12EDGAR2Form 8-K - Current report
      2/01/202416:30BWAlpine Immune Sciences to Participate in Two Upcoming..
      1/22/202418:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/05/202418:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/05/202418:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/05/202416:45EDGAR2Form 8-K - Current report
      1/04/202419:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/04/202419:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      12/21/202316:23EDGAR2Form 8-K - Current report
      12/21/202316:15BWAlpine Immune Sciences Announces Amendment of Acazicolcept..
      12/18/202316:30BWAlpine Immune Sciences to Present at the 42nd Annual J.P...
      11/22/202310:25EDGAR2Form SC 13D/A - General statement of acquisition of..
      11/20/202316:30BWAlpine Immune Sciences to Participate in the Evercore ISI..
      11/15/202309:00BWAlpine Immune Sciences Presents New Translational Data on..
      11/14/202316:15BWAlpine Immune Sciences Reports Third Quarter 2023 Financial..
      11/13/202309:00BWAlpine Immune Sciences Presents New Translational Data on..
      11/06/202321:41BWAlpine Immune Sciences Announces Pricing of $150 Million..
      11/06/202321:37EDGAR2Form FWP - Filing under Securities Act Rules 163/433 of free..
      11/06/202306:05EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
      11/06/202306:02EDGAR2Form 8-K - Current report
      11/06/202306:00BWAlpine Immune Sciences Announces Proposed Public Offering
      11/03/202309:00BWAlpine Immune Sciences Presents New Preclinical Data on..
      11/02/202309:12EDGAR2Form 8-K - Current report
      11/02/202309:00BWAlpine Immune Sciences Presents Initial Clinical Data on..
      10/30/202309:00BWAlpine Immune Sciences to Present New Translational Data on..
      10/13/202309:05BWAlpine Immune Sciences to Present Initial Clinical Data on..
      10/04/202317:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      10/04/202317:11EDGAR2Form 3 - Initial statement of beneficial ownership of..
      10/04/202308:00BWAlpine Immune Sciences Announces Appointment of Wolfgang..
      9/12/202308:30BWAlpine Immune Sciences Presents First Preclinical Data for..
      9/05/202316:30BWAlpine Immune Sciences to Participate in Two Upcoming..
      9/05/202308:30BWAlpine Immune Sciences to Present First Preclinical Data for..
      8/30/202316:30BWAlpine Immune Sciences Announces Initiation of Dosing in 240..
      8/22/202316:30BWAlpine Immune Sciences Announces Appointment of M. Christina..
      8/17/202300:15EDGAR2Form EFFECT - Notice of Effectiveness
      8/14/202316:26EDGAR2Form POS AM - Post-Effective amendments for registration..
      8/14/202316:22EDGAR2Form 8-K - Current report
      8/14/202316:18EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]

      Your Recent History

      NASDAQ
      ALPN
      Alpine Immune Sciences
      Delayed Upgrade Clock